the article for more information about this issue.
Children as Lab Rats
On January 4, 2002, President Bush signed into law the Best Pharmaceuticals for Children Act, which provides incentives for using children in drug trials. The Act offered pharmaceutical companies a six-month exclusivity term in return for their agreement to conduct pediatric tests on drugs. This Act was quickly followed in 2003 by the Pediatric Research Equity Act (PREA). PREA authorizes FDA to require manufacturers of new drug and biologics products to conduct pediatric studies in certain circumstances.
As a result, drug trials on children have gone through the roof.
An article at medicalkidnap.com states that: “In 2006, they found that there were approximately 45,000 children participating in experiments.”
According to Victor Yeung, who is with the Center for Pediatric Pharmacy Research, The School of Pharmacy, at the University of London, over 50% of medicines used on children are not licensed for use either for the stated disease or for the age group.
As it eventuates, the US government is playing fast and hard with informed consent where children are involved. On the surface, it appears that parents must provide consent for children to be enrolled in drug trials. As it plays out in the real world, however, this is not always the case. Parents are often not given adequate information as to the nature of the drug experiments. And in other cases, when the parents raise questions about their children’s medical care, they may find the children taken from them by Department of Children Services. In some cases, they may even have their parental rights terminated by a court.
In 2013, Justina Pelletier was removed from her parents after an emergency trip to the hospital. Justina, who suffers from a rare mitochondrial disease, was re-diagnosed by a new intern at Boston Hospital with “somatoform disorder,” after her parents took her to the Emergency Room with what appeared to be a bad case of the flu. The diagnosis of “somatoform disorder” is a psychiatric diagnosis, which essentially stated that Justina’s disease was “all in her head.” Her parents were unhappy with Boston Hospital’s treatment plan and also with their failure to even consult with her regular doctors and refused to sign off on BH’s treatment plan.
At that point, the hospital notified DCF (aka Child Protective Services) and the Pelletiers were effectively blocked from further unsupervised contact with their daughter. Justina was placed in a locked psychiatric unit and Lou Pelletier was charged with contempt of court for speaking about her circumstances to a Boston Globe reporter.
After an extended court battle and after her plight made national news, Justina was finally returned to her parents’ care. Concerns that she may have been used in experimental drug trials continue.
The Pelletiers are suing Boston Children’s Hospital.
A similar playbook was used against Melissa Diegel, an Arizona mother of two daughters also diagnosed with a rare mitochondrial disease. Diegel has now lost her parental rights after she questioned the treatment plan for her daughters, which was put into place by Phoenix Children’s Hospital and Translational Genomics Research Institute.
In court proceedings fraught with secrecy, removal of witnesses from the courtroom, sealed records and attempts to cast Diegel as someone who had “overmedicalized” her two daughters, Judge Kristin Hoffman severed all parental rights of Melissa Diegel and ordered the two girls to be put up for adoption.
As in the case of Justina Pelletier, where her parents were deemed unfit for following the recommendations of the primary physician and not honoring the diagnosis of a new doctor, the Diegel case reveals efforts by Child Protective Services to demonize Melissa Diegel for following one doctor’s recommendations for treatment for her two daughters, rather than following the recommendations of another doctor.
Melissa Diegel states that Hanna and Kayla were enrolled in TGen drug trials.
The willingness of courts to interfere with parental rights when the children in question can be used for drug trials reveals a systemic imperative wherein science will trump the welfare of individual children. At the center of such experimental imperatives lies organizations such as TGen. You can’t handle the truth about vaccines (Ad)
Translational Genomics Research Institute (TGen) is situated in a modern, multi-story building in Phoenix, Arizona. It was established in 2002 by Dr. Jeffrey Trent, who served for 10 years as the Scientific Director of the National Human Genome Research Institute (NHGRI) at the National Institutes of Health at the National Institutes of Health (NIH) in Bethesda, Maryland, prior to founding TGen.
TGen’s promotional literature states that:
TGen is on the cutting edge of translational research where investigators are able to unravel the genetic components of common and complex diseases. Working with collaborators in the scientific and medical communities, TGen believes it can make a substantial contribution to the efficiency and effectiveness of the translational process. TGen’s vision is of a world where an understanding of genomic variation can be rapidly translated to the diagnosis and treatment of disease in a manner tailored to individual patients.
However, TGen may also be involved in nonconsensual human experimentation. This reporter has uncovered documentation that the Institute maintains agreements with Phoenix Children’s Hospital to refer sick children to the Institute. According to a grant proposal from TGen researcher Dr. Justin Hunter, “Dr. Saunder Bernes, senior pediatric neurologist at Phoenix Children’s Hospital (PCH), has agreed to refer Arizona residents with NMD for these studies (see attached letter of support).” The grant was awarded to Dr. Hunter on October 23, 2014.
As at least two sick children, Hanna and Kayla Diegel, were “referred” to TGen with disastrous results for their family unit, one might question whether or not TGen’s research programs regularly result in terminating family rights.
PCH has continued to deny any such relationship with TGen, even in light of the documents which have surfaced.
TGen maintains numerous contracts with the federal government, including defense contracts. One of these contracts involves sequencing the genome of Burkholderia pseudomallei, which constitutes a Class B bioterror threat.
One of the problems with terminating the parental rights of experimental subjects is that reliable information as to what sorts of experiments are taking place becomes difficult to obtain.
Officials at TGen did not respond to calls from this reporter.
READ MORE HERE: http://www.activistpost.com/2016/03/human-experimentation-rampant-in-the-united-states.html
TPS was created in 2011, in time for our first 9/11 Truth Marathon. Many thanks to Jim and SkyBlueEyes for helping with the background design and layout and Sky, BP, IC Freedom and others for all the hours spent in the Conference room for our Popcorn & Movie Topic Nights.